Edition:
United States

Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

4.06USD
2 Dec 2016
Change (% chg)

$0.09 (+2.27%)
Prev Close
$3.97
Open
$3.97
Day's High
$4.12
Day's Low
$3.91
Volume
948,503
Avg. Vol
1,847,879
52-wk High
$10.95
52-wk Low
$3.78

ACHN.O

Chart for ACHN.O

About

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's primary business is to discover, develop and commercialize small molecule therapeutics for the treatment of infectious diseases and immune system disorders. The Company is focused on its complement inhibitor platform, directed at advancing small... (more)

Overall

Beta: 1.86
Market Cap(Mil.): $604.13
Shares Outstanding(Mil.): 136.68
Dividend: --
Yield (%): --

Financials

  ACHN.O Industry Sector
P/E (TTM): -- 42.21 29.87
EPS (TTM): -0.30 -- --
ROI: -9.70 -1.09 14.95
ROE: -9.71 -2.39 16.29

BRIEF-Achillion Q3 loss per share $0.15

* Achillion Pharmaceuticals Inc says recognized in q3 of 2015 revenue of $33.8 million under janssen agreement

Nov 03 2016

BRIEF-Achillion announces data from phase 2 trial for combination treatment for Genotype 1 Treatment-Naïve HCV

* Announces 100 pct SVR12 In The 6-Week and 8-week cohorts in Janssen'S phase 2 trial evaluating the triple combination treatment regimen including odalasvir, al-335, and simeprevir for genotype 1 treatment-naïve hcv

Sep 23 2016

BRIEF-Achillion, J&J post promising interim data on Hep C combination drug

* Announces 100% SVR Reported In Janssen'S Phase 2a Trial Evaluating Triple Combination Of Odalasvir, Al 335, and simeprevir for genotype 1 treatment-naive HCV

Sep 09 2016

BRIEF-Achillion Pharmaceuticals reports Q2 loss per share $0.14

* Achillion Pharmaceuticals Inc qtrly loss per share $0.14 Source text for Eikon: Further company coverage:

Aug 04 2016

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $31.63 +0.17
Johnson & Johnson (JNJ.N) $111.96 +0.58
Novartis AG (NOVN.S) CHF68.75 -0.10
Merck & Co., Inc. (MRK.N) $61.13 +0.37
Roche Holding Ltd. (ROG.S) CHF220.60 -1.60
Roche Holding Ltd. (RO.S) CHF224.60 -1.10
Abbott Laboratories (ABT.N) $37.90 +0.30
AstraZeneca plc (AZN.L) 4,055.00p -25.00
GlaxoSmithKline plc (GSK.L) 1,467.00p -1.50
Bristol-Myers Squibb Co (BMY.N) $55.96 +0.16

Earnings vs. Estimates